Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medmira Inc receives approval to market reveal rapid HIV test with new features in Europe


Thursday, 13 Mar 2014 05:54am EDT 

Medmira Inc:Receives approval to market enriched version of Reveal HIVtest that simplifies test procedure.Says enabling direct use of whole blood specimens making test even more convenient for point-of-care test users, especially in emergency situations when every second counts.New enhancements build on what is already HIV test among all patented rapid diagnostic technologies available in Europe. 

Latest Developments forMedMira Inc

Company Quote

0.045
 --
1 Jun 2015